viernes, 25 de mayo de 2018

The Brain Tumor Nobody's Heard Of! - Ivanhoe Broadcast News, Inc.

The Brain Tumor Nobody's Heard Of! - Ivanhoe Broadcast News, Inc.


ORLANDO, Fla. (Ivanhoe Newswire) — Vestibular schwannoma, also known as acoustic neuroma is a benign brain tumor that can grow silently for years, often with very subtle symptoms.  Sometimes surgery is the best treatment. There are now a series of high-tech tests doctors use to help map out a successful surgery.

NEW YORK, N.Y. (Ivanhoe Newswire) — Thirty percent of all Americans will be affected by peripheral neuropathy, a condition that impacts nerves leading to the arms and legs. In many cases, doctors prescribe medicines to help manage the pain, burning and tingling. Now, researchers are testing a new non-addictive treatment inspired from a surprising source.

SAN DIEGO, Calif. (Ivanhoe Newswire) — The Zika epidemic started raging in 2015, terrifying the world with images of newborns with terrible birth defects. One researcher, originally from Brazil, is using brain stem cells to find a drug that could treat or even cure infected people.

TAMPA, Fla. (Ivanhoe Newswire) — We’ve all heard how the glass ceiling in business keeps women from making it to the top, and that’s especially true for African American women. But the executive you’re about to meet has electrified her field and is making waves.

ORLANDO, Fla. (Ivanhoe Newswire) — Imagine you or a loved one are walking normally, then slowly you start to shuffle.  You lose bladder control, and possibly most frightening, your memory starts to fade. These are all symptoms that point toward Parkinson’s or Alzheimer’s.

Doctor's In-depth Interview of the week
Slowing Down Seizures​ 

Quote of the week:

How can we even begin to disarm greed and envy? Perhaps by being much less greedy and envious ourselves; perhaps by resisting the temptation of letting our luxuries become needs; and perhaps by even scrutinizing our needs to see if they cannot be simplified and reduced.” 

E.F. Schumacher


Website Information:

Content Licensing:

No hay comentarios:

Publicar un comentario